|
|
| Kürzel | A1MALQ |
| Material | Urin |
| Probengefäß | Urin |
| Abnahmevorschrift | Erster morgendlicher Spontanurin. Alternativ: Zunächst Bestimmung in einer im Tagesverlauf entnommenen Urinprobe (Random urine) und bei pathologischem Befund zusätzlich im ersten Morgenurin zur Bestätigung. |
| Indikation | Nierenschädigung, Proteinurie, V.a. Präeklampsie |
| Bemerkungen zur Analyse | Berechneter Parameter, daher keine separate externe Qualitätskontrolle |
| Literatur | Labor & Diagnose 2020, L. Thomas Hrsg. Kidney Disease: Improving Global Outcome (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013: 3: 1-150. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S266. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-8. Houser MT. Assessment of proteinuria using random urine samples. J Pediatr 1984; 104: 845-8. Houser MT, John MF, Kobayoshi A, Walburn J. Assessment of urinary protein excretion in the adolescent: effect of body position and exercise. J Pediatr 1986; 109: 556-61. Joint Speciality Committee on Renal Medicine of the Royal College of Physicians and the Renal Association and the Royal College of General Practitioners. Chronic Kidney Disease in Adults. www.renal.org/CKDguide/full/ CKDprintedfullguide.pdf (last accessed 9 January 2009). National Institute for Health and Clinical Excellence. Chronic kidney disease: National clinical guideline for early identification and management in adults in primary and secondary care. Clinical Guide 73. 2008. https://www. nice.org.uk/Guidance /CG73 (last accessed 9 January 2009). European Urineanalysis Guidelines. Summary. Scand J Clin Invest 2000; 60: 1-96. |
| letzte Änderung | 24.04.2024 10:02 |